Vanguard Group Inc Nrx Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRXP
# of Institutions
34Shares Held
3.74MCall Options Held
64.6KPut Options Held
9.6K-
Advisor Shares Investments LLC Bethesda, MD615KShares$1.53 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA420KShares$1.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY291KShares$723,8770.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny189KShares$470,0620.0% of portfolio
-
One Wealth Management Investment & Advisory Services, LLC Miami Beach, FL140KShares$349,6000.03% of portfolio
About NRX Pharmaceuticals, Inc.
- Ticker NRXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,641,296
- Market Cap $168M
- Description
- NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...